NCT04783194View on ClinicalTrials.gov

Dexamethasone Plus Bupivacaine Versus Bupivacaine in Bilateral Trans-incisional Paravertebral Block in Lumbar Spine Surgeries .

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

September 15, 2022

Study Completion Date

October 20, 2022

Conditions
Anesthesia
Interventions
DRUG

Dexamethasone+ Bupivacaine

Dexamethasone plus bupivacaine in bilateral trans-incisional paravertebral block in lumbar spine surgery.

DRUG

Bupivacaine

Bupivacaine in bilateral trans-incisional paravertebral block in lumbar spine surgery.

Trial Locations (1)

Unknown

Ain Shams University hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04783194 - Dexamethasone Plus Bupivacaine Versus Bupivacaine in Bilateral Trans-incisional Paravertebral Block in Lumbar Spine Surgeries . | Biotech Hunter | Biotech Hunter